Skip to content

Emily Arsenault

2 papers in the library · 129 citations · publishing 2023-2024

Papers

Sort Most recent Most cited

The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association August 1, 2024 Felipe C Ribeiro, Danielle Cozachenco, Elentina K Argyrousi et al.

Impaired brain protein synthesis, synaptic plasticity, and memory are major hallmarks of Alzheimer's disease (AD). The ketamine metabolite (2R,6R)-hydroxynorketamine (HNK) has been shown to modulate protein synthesis, but its effects on memory in AD models remain elusive. We investigated the effects of HNK on hippocampal protein synthesis, long-term potentiation (LTP), and memory in AD mouse...

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.

Cell Reports March 28, 2023 Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham et al. 129 citations

Hallucinations limit widespread therapeutic use of psychedelics as rapidly acting antidepressants. Here we profiled the non-hallucinogenic lysergic acid diethylamide (LSD) analog 2-bromo-LSD (2-Br-LSD) at more than 33 aminergic G protein-coupled receptors (GPCRs). 2-Br-LSD shows partial agonism at several aminergic GPCRs, including 5-HT2A, and does not induce the head-twitch response (HTR) in...